The effects of concurrent oral paliperidone or risperidone use with paliperidone long-acting injection

Volume: 11, Issue: 1, Pages: 12 - 18
Published: Jan 1, 2021
Abstract
Dosing recommendations for paliperidone long-acting injectable antipsychotic (LAIA) do not include oral antipsychotic (OAP) overlap; however, OAPs are often given concurrently despite limited evidence describing both the risks and benefits of this practice.A retrospective chart review was conducted in patients initiated on paliperidone palmitate (PP) during a psychiatric hospitalization to compare patients who received OAP overlap versus those...
Paper Details
Title
The effects of concurrent oral paliperidone or risperidone use with paliperidone long-acting injection
Published Date
Jan 1, 2021
Volume
11
Issue
1
Pages
12 - 18
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.